OCT 23, 2019 10:37 AM PDT

Why the Michael J. Fox Foundation Advocates for Cannabis Research

WRITTEN BY: Julia Travers

The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which was established by and is named after the actor who has the disease, continues to advocate for cannabis research. As reported by Marijuana Moment, the group is currently pushing Congress to pass three bills relating to cannabis research and medical marijuana; the Medical Cannabis Research Act, VA Medicinal Cannabis Research Act and Expanding Cannabis Research and Information Act.

“Our role on the public policy team is to work with Congress and the administration to ensure there is access and funding for research and care initiatives that can benefit people living with Parkinson’s and, right now, that includes access to medical cannabis for research,” Ted Thompson, the foundation’s senior vice president of public policy, said. According to the MJFF site, the public policy team is currently tracking these bills and aims to inform members of Congress and their staff as to why the bills matter to the Parkinson’s community.

The bills MJFF supports have various goals. The Medical Cannabis Research Act would require the Justice Department to approve more research-grade cannabis manufacturers, provide protection to research organizations that study marijuana, and authorize the Department of Veterans Affairs (VA) to tell patients about the option to participate in federal cannabis studies.

Under the VA Medicinal Cannabis Research Act, the VA would investigate marijuana’s therapeutic potential in regard to treating conditions that often affect veterans, like PTSD or chronic pain.

The Expanding Cannabis Research and Information Act would reschedule marijuana from a Schedule I to Schedule III within the U.S. Controlled Substances Act (CSA), and alter current regulatory requirements in order to permit institutions of higher learning to study cannabis.

Earlier, in 2018 and 2019, MJFF also submitted comments to the Food and Drug Administration in favor of rescheduling.

“Right now, more research is needed to better understand if cannabis (including marijuana and CBD products) could treat Parkinson’s disease,” the foundation site states.

Article sources: Marijuana Moment, Michael J. Fox Foundation

 
About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JAN 22, 2020
Cannabis Sciences
JAN 22, 2020
People Struggling with Pain Also Struggle with Cannabis Use Disorder
The hype in the media that surrounds cannabis and health benefits supposedly associated with its use may be detrimental ...
FEB 18, 2020
Cannabis Sciences
FEB 18, 2020
Is it Better to Vape THC or Smoke Marijuana?
Vaping THC is becoming increasingly popular. But is it better than simply smoking marijuana out of a joint? How does it ...
APR 04, 2020
Cannabis Sciences
APR 04, 2020
Only 50% Cannabis Genome Has Been Mapped
As more and more jurisdictions are decriminalizing cannabis usage, its popularity both for medicinal and recreational us ...
APR 16, 2020
Cannabis Sciences
APR 16, 2020
Nanoemulsion Speeds up THC Absorption in Edibles
Cannabis products infused with nanoemulsion boast many advantages over more traditionally manufactured edibles, and are ...
APR 16, 2020
Cannabis Sciences
APR 16, 2020
Even the Most Experienced Cannabis Users Don't Understand Cannabinoids
Results from a new research study call for better cannabis education programs after a survey of potentially the drug&rsq ...
MAY 16, 2020
Cannabis Sciences
MAY 16, 2020
Body's Own Cannabis Helps Us Forget Traumatic Events
Researchers have found that anandamide, often referred to as the body’s own cannabis, may help us forget traumatic ...
Loading Comments...